BioConnection, your boutique CMO

A unique formula

As a boutique CMO, BioConnection provides highly tailored solutions to innovative biopharmaceutical companies for their clinical and commercial products.You have access to our state-of-the-art GMP manufacturing facilities. Combined with a wealth of experience, support services and a personal approach, we enable you to develop and manufacture (filling and freeze-drying) your injectable (bio)pharmaceutical products.We are your contract services and manufacturing organization, located in the Netherlands, with a worldwide customer base and a successful commercial track record at both the FDA and EMA.

Our goal

Our goal is to provide tailored solutions with high levels of commitment and quality. We do this with our CMC service cornerstones: drug product development, fill and finish, freeze-drying and finished product services.

Our values

With BioConnection, you get a committed, reliable and flexible boutique CMO with a personal touch.



fill and finish

fill and finish

Freeze drying

Finished product

Any specific needs?

Challenge us with your question by filling in this form immediately!


Our building blocks to fullfill your needs. You can tailor our services to your specific needs.

GMP manufacturing facility

  • Aseptic filling
  • Freeze drying
  • Terminal sterilization
  • Batch certification
  • EMA and US-FDA track record
  • Automated fill
  • Manual fill, labelling and packaging
  • Batch volume: Up to 500L
  • Freeze-drier: Shelf surface 1 x 3 m2 and 1 x 10 m2

Personalised medicine

  • Microspheres
  • Flexible GMP cleanroom setup

‘ResoTher Pharma ApS is truly amazed by BioConnection’s commitment to our Fill&Finish project.’

‘One of the very best experiences of tech transfer, development, scale-up and manufacture’

Why choose BioConnection?

We solve your challenges

For many APIs you have

“We provide solutions, creativity and solve challenges for your product. And yes, we also reliably provide top notch fill and finish for you from clinics to market.”

[Alexander Willemse – CEO]